Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance

Laryngoscope

Volumn 119, Issue 11, 2009, Pages 2135-2140

  Agrawal, Amit ^a   Hammond, Thomas H ^a   Young, Gregory S ^a   Avon, Amanda L ^a   Ozer, Enver ^a   Schuller, David E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Recurrent head and neck cancer; Salvage; Surveillance; Survival

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RECURRENT CANCER; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; SYMPTOM;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; POPULATION SURVEILLANCE; SURVIVAL RATE; TIME FACTORS;

EID: 73449098971     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20527     Document Type: Article

References (10)

1. The NCCN Clinical Practice Guidelines in OncologyTM - Head and Neck Cancers, Version 2.2008. Copyright 2009 National Comprehensive Cancer Network, Inc. Available at: www.nccn.org. Accessed April 26, 2009. To view the most recent and complete version of the NCCN Guidelines, go online to www.nccn.org.
2. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426-430.
3. Agrawal A, DeSilva B, Buckley B, Schuller DE. Role of the physician vs. the patient in the detection of recurrent disease following treatment for head and neck cancer. Laryngoscope 2004;114:232-235.
4. Stierer M, Rosen HR. Influence of early diagnosis on prognosis of breast cancer. Cancer 1989;64:1128-1131.
5. Roselli Del Turco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 1994;271: 1593-1597.
6. Cochrane JPS, Williams JT, Faber RG, Slack WW. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. Br Med J 1980;280:593-595.
7. Walsh GL, O'Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost effective? Ann Thorac Surg 1995;60:1563-1570.
8. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest 1999;115:1487-1488.
9. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: The Radiation Therapy Oncology Group Trial 91-11. Arch Otolaryngol Head Neck Surg 2003;129:44-49.
10. Fleming AJ, Smith SP, Paul CM, et al. Impact of [18F]-2- fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007;117: 1173-1179.